Antibiotic (ATB) Treatment strategy | |||
---|---|---|---|
ATB for all symptomatic patients (i.e.no RUT used) | ATB only in patients with positive RUTa | ||
Patients treated (%) | 347 (100) | 311 (89) | |
Appropriate ATB decision b (%) | 253 (73) | 278 (80) | 0.02d |
No ATB, negative UCc | 0 | 31 | |
ATB, positive UC | 253 | 247 | |
Inappropriate ATB decision (%) | 94 (27%) | 70 (20%) | |
ATB, negative UC | 94 | 64 | |
No ATB, positive UC | 0 | 6 | |
Overall susceptibility rates according to the ATB regimen e (%) | |||
Fosfomycin | 89 | 90 | |
Nitrofurantoin | 98 | 98 | |
TMP-SMX | 85 | 86 | |
Ofloxacin | 94 | 95 | |
Pivmecillinam | 76 | 78 | |
Fosfomycin, except if RUT- | |||
For nitrites and age < 30: nitrofurantoin | 93 | ||
Fosfomycin, except if RUT- | |||
For nitrites and age < 30: ofloxacin | 93 |